MOH — authorised 18 May 2023
- Marketing authorisation holder: BAUSCH AND LOMB INC
- Status: likely_approved
MOH authorised Miebo on 18 May 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 18 May 2023.
BAUSCH AND LOMB INC holds the UAE marketing authorisation.